Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | La Merie | Competitor Analysis: Systemic Lupus Erythematosus (SLE)

Competitor Analysis: Systemic Lupus Erythematosus (SLE)

The present Competitive Intelligence Report about new developments in the pipeline for treatment of Systemic Lupus Erythematosus (SLE), Lupus Nephritis and Cutaneous Lupus Erythematosus (CLE) provides a competitor evaluation in the field of R&D projects for treatment of SLE, Lupus Nephritis and CLE as of February 2008.

The report includes a compilation of current active projects in research and development of predominantly antibodies against various targets for treatment of systemic lupus erythematosus (SLE), lupus nephritis, cutaneous lupus erythematosus (CLE) and autoimmune diseases in general (preclinical stage). Among major competitor companies are GlaxoSmithKline, Wyeth, AstraZeneca, Roche, Bristol-Myers Squibb and many other companies. At least six antibodies are in pivotal clinical development. Competitor projects are listed in a tabular format providing Information on:

* Drug Codes,

* Target / Mechanism of Action,

* Class of Compound,

* Company,

* Product Category,

* Indication,

* R&D Stage and

* additional comments with a hyperlink leading to the source of information.

Index

* Systemic Lupus Erythematosus (SLE)

* Lupus Nephritis

* Cutaneous Lupus Erythematosus (CLE)

* Autoimmune diseases (preclinical)

* About La Merie

About Competitor Analysis Series

The Competitor Analysis Series delivers NO-FRILLS , but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Publisher: La Merie

Product Line: Competitor Analysis

Pages: 10

Release Date: February of 2008

Format: PDF

Product Code: LMCA0100

Price

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions